Reinhorn, Daniel
Yerushalmi, Rinat
Moore, Assaf
Desnoyers, Alexandra
Saleh, Ramy R.
Amir, Eitan
Goldvaser, Hadar http://orcid.org/0000-0002-9557-4634
Article History
Received: 3 April 2020
Accepted: 26 May 2020
First Online: 1 June 2020
Compliance with ethical standards
:
: Dr. Yerushalmi reports personal fees from: Roche (Consulting, Invited speaker), Pfizer (Consulting), Novartis (Consulting), Teva (Invited speaker), Medison (Invited speaker), MSD (Invited speaker), Astra-Zeneca (Invited speaker) and Novartis (Invited speaker), all outside the submitted work. Dr. Moore reports <i>honorarium</i> fees from MSD and Roche, all outside the submitted work. Dr. Amir reports personal fees from Genentech/Roche (Expert Testimony), personal fees from Apobiologix (Consulting), personal fees from Myriad Genetics (Consulting), personal fees from Agendia (Consulting), personal fees from Sandoz (Consulting), all outside the submitted work. Dr. Goldvaser reports personal fees from: Roche (honorarium), Pfizer (honorarium), Novartis (honorarium and consulting) all outside the submitted work. The other authors have no conflicts of interest to declare.